Table 1.
Summary of recommended vaccines for pregnant and postpartum women.
| Target Population | Vaccine | Type/Form | Recommendation |
|---|---|---|---|
| All pregnant women | Influenza | Inactivated | 1 dose administered during flu at any gestational ages |
| Tetanus, Diphtheria and acellular Pertussis (Tdap) | Toxoid/inactivated bacteria | 1 dose ideally between 27 and 36 weeks of gestation | |
| Pregnant women with specific risk factors | Hepatitis A | Inactivated whole-cell viral | 2 doses; allowed in some circumstances |
| Hepatitis B | Inactivated viral recombinant subunit | 3 doses; allowed in some circumstances | |
| Pneumococcal | Inactivated bacteria polysaccharide | 1 dose if there is risk factor | |
| Meningococcal | Inactivated bacteria polysaccharide | 1 dose if there is risk factor | |
| Conjugate | |||
| Yellow fever | Live-attenuated viral | 1 doses during epidemics and in case of travel to endemic regions. (Should be avoided during breastfeeding) | |
| Japanese Encephalitis | Live-attenuated viral | 1 doses during epidemics and in case of travel to endemic regions | |
| Typhoid | Live-attenuated bacterial recombinant | Insufficient data for recommendation | |
| Anthrax | Inactivated subunit | Post-exposure prophylaxis; pre-exposure prophylaxis is not recommended | |
| Rabies | Inactivated whole-cell viral | Post-exposure prophylaxis; consider pre-exposure prophylaxis if risk of exposure is very high | |
| Tetanus and Diphteria (Td) | Inactivated bacterial toxoids | Allowed in some circumstances (Tdap preferred) | |
| Smallpox | Live-attenuated viral | Post-exposure prophylaxis; pre-exposure prophylaxis is not recommended | |
| Postpartum women (contraindicated in pregnancy) | MMR (Measles, Mumps, Rubella) | Live-attenuated viral | 1 dose immediately postpartum if susceptible to rubella |
| Varicella | Live-attenuated viral | 1 dose immediately postpartum if susceptible |